e7aa3952_ed_Radionuclide_Therapy___HTML_euticals_for_targeted_therapy__Targeting_mechanism
[Radiopharmaceutical] Y-90 Ibritumomab tiuxetan [Indications] Non-Hodgkin's lymphoma [Targeting mechanism] 
CD20 Antigen binding
Cancers | Free Full-Text | Targeted Radionuclide Therapy | HTML